Tag: Liver Disease: Misc.
COVID-19-Related Alcohol Consumption Will Increase Liver Disease
One-year increase in alcohol consumption to result in 8,000 additional liver disease-related deaths
Bariatric Surgery Cuts Hepatic Steatosis in Obesity and T2DM
Similar decline in liver fat fraction seen for sleeve gastrectomy, Roux-en-Y gastric bypass from surgery to one-year follow-up
Number of Elderly on U.S. Liver Transplant List Rising
Outcomes for elderly patients receiving liver transplants also improving
Bariatric Surgery May Cut Risk for Adverse Outcomes in NASH
Risk for adverse liver and cardiovascular outcomes lower among patients with obesity and advanced fatty liver who undergo bariatric surgery
Liver Transplant Outcomes Worse for Nonoverweight NAFLD Patients
Outcomes worse before and after liver transplant for nonoverweight versus overweight/obese adults with nonalcoholic fatty liver disease
Some Cirrhosis Patients Given Opioid Rx at Outpatient Visits
Authors say primary care providers in particular need more education on the potential harms of opioids in patients with liver disease
Higher Serum Iron May Up Liver Cancer Risk in NAFLD Patients
Increased risk for hepatocellular carcinoma also seen with higher transferrin saturation levels in patients with nonalcoholic fatty liver disease
Fibrosis Stages F3, F4 in NAFLD Linked to Higher Mortality Risk
Incidence of all-cause mortality increased with increasing fibrosis stage; increase also seen in liver-related complications
Lanifibranor Reduces Disease Activity in Nonalcoholic Steatohepatitis
In phase 2b trial, more patients with active NASH had reduction in disease activity score with lanifibranor versus placebo
Survival Rates Lower for Black Liver Transplant Recipients
For Blacks versus Whites, differences in post-LT mortality narrowed between 2002 and 2009, increased between 2014 and 2018
